Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients

Abstract Intraocular surgery is associated with increased ocular inflammation. If maintained for a prolonged period after surgery, this inflammation can cause various complications, including subconjunctival fibrosis and bleb scarring. This clinical trial was a prospective, randomised, single-blind,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takehiro Matsumura, Kentaro Iwasaki, Shogo Arimura, Ryuji Takeda, Yoshihiro Takamura, Masaru Inatani
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d9be729e85cf4727a85f409aaa727731
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9be729e85cf4727a85f409aaa727731
record_format dspace
spelling oai:doaj.org-article:d9be729e85cf4727a85f409aaa7277312021-12-02T16:31:07ZTopical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients10.1038/s41598-021-85495-w2045-2322https://doaj.org/article/d9be729e85cf4727a85f409aaa7277312021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85495-whttps://doaj.org/toc/2045-2322Abstract Intraocular surgery is associated with increased ocular inflammation. If maintained for a prolonged period after surgery, this inflammation can cause various complications, including subconjunctival fibrosis and bleb scarring. This clinical trial was a prospective, randomised, single-blind, interventional study comparing the efficacy and safety of 0.1% bromfenac sodium ophthalmic solution and 0.02% fluorometholone ophthalmic suspension in the inhibition of multiple inflammatory cytokines in the aqueous humour of 26 patients with pseudophakic eyes who had undergone phacoemulsification and intraocular lens implantation. The patients were randomly assigned to one of the trial drugs, and aqueous humour samples were collected before and after drug administration. Platelet-derived growth factor-AA levels significantly decreased in both drug groups, but they were significantly higher in the fluorometholone group than in the bromfenac group (P = 0.034). Bromfenac also significantly decreased vascular endothelial growth factor level (P = 0.0077), as well as monocyte chemoattractant protein-1 level (P = 0.013), which was elevated for a prolonged period after phacoemulsification. These data suggest that bromfenac is useful to alleviate prolonged microenvironmental alterations in the aqueous humour of pseudophakic eyes.Takehiro MatsumuraKentaro IwasakiShogo ArimuraRyuji TakedaYoshihiro TakamuraMasaru InataniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Takehiro Matsumura
Kentaro Iwasaki
Shogo Arimura
Ryuji Takeda
Yoshihiro Takamura
Masaru Inatani
Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
description Abstract Intraocular surgery is associated with increased ocular inflammation. If maintained for a prolonged period after surgery, this inflammation can cause various complications, including subconjunctival fibrosis and bleb scarring. This clinical trial was a prospective, randomised, single-blind, interventional study comparing the efficacy and safety of 0.1% bromfenac sodium ophthalmic solution and 0.02% fluorometholone ophthalmic suspension in the inhibition of multiple inflammatory cytokines in the aqueous humour of 26 patients with pseudophakic eyes who had undergone phacoemulsification and intraocular lens implantation. The patients were randomly assigned to one of the trial drugs, and aqueous humour samples were collected before and after drug administration. Platelet-derived growth factor-AA levels significantly decreased in both drug groups, but they were significantly higher in the fluorometholone group than in the bromfenac group (P = 0.034). Bromfenac also significantly decreased vascular endothelial growth factor level (P = 0.0077), as well as monocyte chemoattractant protein-1 level (P = 0.013), which was elevated for a prolonged period after phacoemulsification. These data suggest that bromfenac is useful to alleviate prolonged microenvironmental alterations in the aqueous humour of pseudophakic eyes.
format article
author Takehiro Matsumura
Kentaro Iwasaki
Shogo Arimura
Ryuji Takeda
Yoshihiro Takamura
Masaru Inatani
author_facet Takehiro Matsumura
Kentaro Iwasaki
Shogo Arimura
Ryuji Takeda
Yoshihiro Takamura
Masaru Inatani
author_sort Takehiro Matsumura
title Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
title_short Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
title_full Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
title_fullStr Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
title_full_unstemmed Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
title_sort topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d9be729e85cf4727a85f409aaa727731
work_keys_str_mv AT takehiromatsumura topicalbromfenacreducesmultipleinflammatorycytokinesintheaqueoushumourofpseudophakicpatients
AT kentaroiwasaki topicalbromfenacreducesmultipleinflammatorycytokinesintheaqueoushumourofpseudophakicpatients
AT shogoarimura topicalbromfenacreducesmultipleinflammatorycytokinesintheaqueoushumourofpseudophakicpatients
AT ryujitakeda topicalbromfenacreducesmultipleinflammatorycytokinesintheaqueoushumourofpseudophakicpatients
AT yoshihirotakamura topicalbromfenacreducesmultipleinflammatorycytokinesintheaqueoushumourofpseudophakicpatients
AT masaruinatani topicalbromfenacreducesmultipleinflammatorycytokinesintheaqueoushumourofpseudophakicpatients
_version_ 1718383903447711744